Live Breaking News & Updates on Cellera Biologics

Stay updated with breaking news from Cellera biologics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AbCellera Biologics (NASDAQ:ABCL) Sees Large Volume Increase

AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) shares saw an uptick in trading volume on Tuesday . 629,336 shares traded hands during mid-day trading, a decline of 54% from the previous session’s volume of 1,372,934 shares.The stock last traded at $4.07 and had previously closed at $3.85. Analyst Upgrades and Downgrades Several research firms […] ....

Stifel-nicolaus , Abcellera-biologics , Capital-partners , Schonfeld-strategic-advisors , Abcellera-biologics-inc , Nasdaq , Keycorp , Get-free-report , Cellera-biologics , Strategic-advisors , Forest-capital-management , Cellera-biologics-inc

AbCellera Biologics (NASDAQ:ABCL) Issues Earnings Results

AbCellera Biologics (NASDAQ:ABCL) Issues Earnings Results
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Stifel-nicolaus , Abcellera-biologics , Keycorp , Abcellera-biologics-inc , Get-free-report , Cellera-biologics , Cellera-biologics-inc , Abcellera-biologics-daily ,

Bloom Burton Comments on AbCellera Biologics Inc.'s FY2026 Earnings (NASDAQ:ABCL)

Bloom Burton Comments on AbCellera Biologics Inc.'s FY2026 Earnings (NASDAQ:ABCL)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Abcellera-biologics , Stifel-nicolaus , Abcellera-biologics-company-profile , Capital-partners , Schonfeld-strategic-advisors , Abcellera-biologics-inc , Keycorp , Nasdaq , B-riley-wealth-advisors-inc , Free-report , Bloom-burton , Abcellera-biologic

AbCellera Biologics (NASDAQ:ABCL) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS

AbCellera Biologics (NASDAQ:ABCL) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Abcellera-biologics , Stifel-nicolaus , Abcellera-biologics-inc , Nasdaq , Keycorp , Get-free-report , Cellera-biologics , Cellera-biologics-inc , Abcellera-biologics-daily ,

Brokerages Set AbCellera Biologics Inc. (NASDAQ:ABCL) Price Target at $15.86

Brokerages Set AbCellera Biologics Inc. (NASDAQ:ABCL) Price Target at $15.86
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

China , Stifel-nicolaus , Abcellera-biologics , Seelaus-asset-management , Truemark-investments , Mirae-asset-global-investments-co , Abcellera-biologics-inc , China-universal-asset-management-co , Nasdaq , Get-free-report , Marketbeat-ratings , Cellera-biologics